Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
KKM-181C by Kolmar Korea for Idiopathic (Essential) Hypertension: Likelihood of Approval
KKM-181C is under clinical development by Kolmar Korea and currently in Phase I for Idiopathic (Essential) Hypertension. According to GlobalData,...